Search Results for: David Rheins

MJBA Founder David Rheins Picks The Hottest Hemp, CBD, Vape & Culture+ Products Of 2019 At ASD Market Week | Culture+

VIP Panel Will Include Founders of Elixinol, The Blinc Group, Curved Papers and Farmer Tom Hemp Co.

NEVADA: The Culture+ marketplace is exploding, with thousands of new legal hemp, CBD, vape and cannabis-culture products creating consumer excitement and marketplace disruption.

MJBA at ASD

MJBA’s founder and executive director David Rheins, a seasoned marketing executive who learned his chops playing senior roles for Rolling Stone, SPIN, Time Warner AOL, has scoured the country to find The Hottest Hemp, CBD & Culture+ Products of 2019, which he’ll present at the ASD Market Week | Culture+ convention in Las Vegas on Monday, March 18, 9:00 AM – 9:45 AM.

Screenshot 2018-12-10 16.46.33These are the products that every retailer must know about – from hemp-based fashions and CBD health and beauty aids, to the latest in vaporizer technology and glassware.

Screenshot 2018-12-10 14.26.21

Following the 45-minute presentation, moderator David Rheins will lead a VIP Panel Discussion with the brand marketers who are building the industries best and most innovative brands, including Elixinol co-founder David Newman, The Blinc Group CEO Sasha Aksenov, Farmer Tom Hemp Co. Founder Tom Lauerman, and Curved Papers Founder Michael O’Malley.

Hemp is projected to be a $22 Billion market by 2012. Get an advanced look at all the hottest products, trends and technologies driving the red-hot Culture+ market.

Registration for the show is available online.

David Rheins Keynote Address At Indiana Cannabis Chat 1.0

The following is a transcript of MJBA Executive Director David Rheins’ keynote speech at Indiana Cannabis Chat 1.0, last week’s educational mixer held at the historic Antelope Club in downtown Indianapolis.  The event was produced put by the Indiana Libertarian Party of Marion County, and sponsored by Curved Papers.


Thank you, it is an honor to be able to address this historic first Indiana Cannabis Chat 1.0 event.

As Chris mentioned, my name is Dave Rheins. I am the founder and executive director of the Marijuana Business Association, or MJBA.  MJBA is a national trade organization serving the legal cannabis industry.  We represent hundreds of licensed cannabis businesses and the many professional services companies upon whom they rely.  We support grassroots communities in Washington, Oregon, Colorado and New York/New Jersey with plans to add more as new legal states like California, Nevada, Massachusetts and Maine come online.

We host professional networking meetups, educational panels, seminars and workshops, host job fairs and vendor fairs, and run several cannabis-related media sites, including MJHeadlineNews, Marijuana Channel One and the MJNewsNetwork.

I am a Hoosier, born and raised in Indiana.  I grew up in Indianapolis, graduated North Central and Indiana University, where I studied Journalism and English.

I spent my professional career at the intersection of popular culture, technology and commerce at places like Rolling Stone, SPIN and AOL Time Warner.  My work with the MJBA is a natural part of that continuum.  Pot Culture is Pop Culture.

MJBA was founded in 2012, before Colorado or Washington passed their historic voter initiatives legalizing adult personal use of cannabis, creating the first regulated pot marketplaces.

After 80 years of prohibition, our challenge was to create, from the ground up, a system of producing, processing and retailing a heretofore illicit product. Not only did we need to put in place the mechanisms of a whole new marketplace, we needed to reintegrate the underground cannabis industry and lifestyle into the mainstream economy.  Normalization is our greatest challenge.

Legalization came by way of voter initiative, not legislation. Meaning that the people and not the political parties heralded in this enormous societal change. In fact, no major politician supported Washington’s I-502 or Colorado’s Proposition 64. And when both passed, the state was mandated to create a system for regulating, taxing and supervising this nascent industry.  Every new legal state has had to create a system of commerce – and a regulatory schema that worked.  Each of the 8 legal states has its own idiosyncratic set of rules and regs, and within each state, counties and municipalities add their own layer of rules and taxes, or in some case opt out of legal pot altogether.  Your participation in the education and advocacy in your community is crucial.

The challenge has been enormous, made only more difficult due to the complexities of federal prohibition – which restricts the growth of the industry by inhibiting its access to those things it needs to grow: everything from simple banking and commercial capital, to medical research.  Legal cannabis businesses operate at an extreme disadvantage when it comes to taxation.  IRS Code Section 280-E restricts these state-regulated and legal businesses from deducting anything beyond simple COGS (Cost of Goods Sold), and the resultant high tax level making profitability elusive indeed.

Federally, marijuana is still classified as a Schedule 1 substance under the Controlled Substances Act.  Federal prohibition has resulted in a crazy-quilted patchwork of state industries, no two alike, as every state government, and every community within these legal jurisdictions decide what legal cannabis will look like.  And it is here that there is the greatest opportunity for the entrepreneur and independent investor.

It is at the state and local level that decisions are being made as to what legal products will be available, how they are grown, tested for quality and safety, packaged, distributed, advertised, marketed, sold and taxed.  Decisions about potency, are being made by local participants in each community.  Early entrants are uniquely being given the opportunity to define the marketplace.  While our cannabis revolution is national, and indeed international in scope – the biggest opportunities are local.

 Indiana will have the opportunity to build the legal cannabis marketplace that works best for its citizenry.

Let’s level set the business opportunity.  According to the National Conference of State Legislatures, A total of 29 states, the District of Columbia, Guam and Puerto Rico now allow for comprehensive public medical marijuana and cannabis programs.  In addition, 17 states allow use of “low THC, high cannabidiol (CBD)” products for medical reasons in limited situations or as a legal defense. Those programs are not counted as comprehensive medical marijuana programs.

Indiana’s House Bill 1148 would legalize the use of cannabidiol for patients with treatment-resistant epilepsy. The oil is derived from the cannabis plant but would be allowed to contain only up to .3 percent THC.

Eight states and the District of Columbia now have legalized small amounts of marijuana for adult recreational use.

The legal cannabis industry is the fastest growing industry in our economy. Tens of thousands of new licensed cannabis companies have created hundreds of thousands of new jobs and generated hundreds of millions in new tax revenues.

According to New Frontier Data, legal consumer spending across North America grew 34 percent in 2016 to $6.7 billion and can be expected to grow at a 27 percent compound annual growth rate (CAGR) over the next five years, to $22.6 billion in 2021

“While the uncertainty created by the mixed signals coming out of the Administration may cause a temporary dip in some valuations of cannabis companies and some more risk-averse institutional investors and multinational companies may continue to stay on the sidelines, it won’t impact the growth of the market much at all,” said Troy Dayton, CEO of ArcView Market Research. “No matter what the administration does, states will continue to issue cannabis licenses to a long line of applicants and licensed cannabis outlets will continue to have long lines of consumers ready to purchase this product from regulated establishments.”

More facts:

  • North Americans spent $56.1 billion on legal and illicit cannabis products in 2016, about half of the $105 billion they spent on beer. But only $6.7 billion of that was spent legally and 87 percent of that came from just five states and Canada;
  • Growth in legal cannabis sales has already eroded the illicit market. This erosion will greatly accelerate in 2018 with the arrival of legalized adult-use programs in North America’s two biggest markets, California and Canada. Meanwhile, the 20 states without legal cannabis programs contributed nothing to the accelerating erosion of the illicit market;
  • Voters in Florida, Arkansas, Montana, and North Dakota passed medical cannabis initiatives in 2016.  This means that 63 percent of Americans can legally obtain cannabis with a doctor’s recommendation;
  • Voters in California, Massachusetts, Nevada, and Maine passed adult-use measures in 2016. This more than tripled the portion of Americans that will be able to purchase cannabis without a doctor’s recommendation in their home state to 21 percent; Compound annual growth rates above 50 percent since adult-use legalization in Colorado and Washington drew significant new segments of the investment community into the legal cannabis industry in 2016, driving triple-digit gains in public stocks and double-digit gains in capital raised by operating companies and a growing group of cannabis-focused investment funds;

For Hoosier investors who want to capture some of the industry’s rapid financial growth, but aren’t able or don’t want to get involved with plant-touching firms that grow or sell cannabis and products still prohibited under federal law, lots of opportunities exist.   Here are some of my favorites:

    • Real Estate
    • Logistics/Distribution
    • Software
    • Security
    • Lighting
    • Soil
    • Hardware: big ag tech for growers, extraction machines for processors, and point of sale for retail; consumer products (vapes and accessories)
    • Nutrients and hydroponics
    • Testing, Labs & Quality control
    • Genetics
    • Packaging
    • Branding, Marketing and promotion
    • Business Intelligence
    • Professional services – Legal, Accounting, Business planning
    • Investment – penny stocks, equity and debt investment

Hemp is the most immediate opportunity for Hoosiers.

According to Vote Hemp approximately 9,650 acres of hemp crops were planted in 15 states during 2016 in the U.S., 30 universities conducted research on hemp cultivation, and 817 State hemp licenses were issued across the country. This hemp cultivation is legal in 32 states, which have lifted restrictions on hemp farming and may license farmers to grow hemp in accordance with Sec. 7606 of the Farm Bill, the Legitimacy of Industrial Hemp Research amendment.

Historically: Indiana has had a long and proud hemp history.  In 1930, it was the third largest crop grown in the state. And in 1940, there were six hemp processing plants in Indiana alone.

Hemp was grown widely until the 1970s Controlled Substances Act. 2 acres of hemp were cultivated in Indiana last year for research purposes.

Today:  Indiana Hemp Law   Year Passed: 2014 Summary: Senate Bill 357 authorizes state regulators to begin the process of licensing farmers to grow hemp commercially.The American Farm Bureau led by the Indiana Farm Bureau recently endorsed ending the federal prohibition on industrial hemp at its annual meeting in January.

Most recently, the US House of Representatives approved language in the federal Farm Bill to allow pilot studies specific to hemp cultivation to take place in states that have authorized them. Indiana’s farmers ought to be able to take advantage of this pending change in federal law.
Statute:
 Ind. Code § 15-15-13-7 (2014)

Gov. Eric Holcomb signed Indiana’s first medical cannabis legislation in April. It legalizes cannabidiol or CBD – for the treatment of epilepsy.

How will Growing & Processing of CBD be governed in Indiana?

Kentucky grew more than 2500 acres of hemp last year, making it the second largest producer behind Colorado. The Hemp CBD representing $130 million in sales in 2016 with growth at a 53% AGR (Adjusted Growth Revenue).

CannaFest Destiny:

A recent editorial in the Indy Star from Indiana Attorney General Curtis Hill, whom I understand will be in this same hall tomorrow, acknowledges that legalization is sweeping the country and the unstoppable trend is headed this way.  Legalization is coming to Indiana, sooner than you think.

The question for you thought-leaders in the audience should be HOW to get in on the ground floor of this emerging market.  We suggest that you start by 1) Getting Informed 2) Getting Connected  3 )Activating attend conferences, organize more Cannabis Chats and join groups – political and business.


See related article: http://mjnewsnetwork.com/events/cannafest-destiny-tour-stops-at-first-church-of-cannabis-in-indy-on-june-13th-2018/

 

 

 

 

 

 

 

Witnessing The Birth of An Industry: MJBA CEO David Rheins Looks Back At 2014

By David Rheins 

2014 has been an amazing year for those of us on the front lines of the legal cannabis movement. Thanks to the support of the now 300+ cannabis business members, dozens of sponsors and thousands of supporters, the b2b trade group I run, Marijuana Business Association (MJBA), has grown rapidly.  We’ve been busy during our first full year of operations helping our young industry lay the foundation for what will be one of  Washington State’s — and eventually the nation’s — major economic drivers.  Here are some of the year’s highlights:

Women of Weed

Women of Weed

As the industry grows, so do we: MJBA business groups now meetup regularly in Seattle, Tacoma, Vancouver, and Spokane, WA. And in the first quarter of 2015, we’ll expand these networking events to support cannabis business communities in Denver, CO and Portland, OR.

600_343201432

In the past year we’ve focused most of our energies helping to build Washington’s nascent legal cannabis business community. Focusing on our core values of providing reliable business intelligence, community and opportunity, MJBA organized two major b2b Vendor Fairs this year — both at Seattle’s Magical Butter Studios.  Our inaugural MJBA Vendor Fair in March 2014, came just as the first recreational marijuana licenses were being issued by the LCB.  That historic event, sponsored by leading edible company Evergreen Herbal, saw more than 300 businesses participate – with 25 sponsor/vendors.  Our second iteration,  MJBA Vendor Fair Summer, sponsored by Blue Line Protection Group, happened just days before the opening of Washington’s first legal pot shops and saw 20 vendors and 200 attendees who made crucial contacts and business deals.

Evergreen Herbal chief Marco Hoffman on stage at Vendor Fair.

Evergreen Herbal chief Marco Hoffman on stage at Vendor Fair.

MJBA_VendorFairPicsAnimation

In between those two events, we launched the MJBA Women’s Alliance with an elegant power luncheon at the Columbia Tower Club, featuring a keynote speech by LEAP’s Diane Wattles Goldstein, guest appearance by Cheryl Shuman. Ah Warner, Cannabis Basics founder, and creator of Women of Weed, was presented with a lifetime achievement award.

MJBA Women's Alliance Luncheon

MJBA Women’s Alliance Luncheon

Later in May also saw the debut of MJBA’s first Professional Education Seminar, “Canna Business and the Law.” Sponsored by Canna Law Group and emceed by CNBC’s Al Olson, the event featured VIP Keynotes by Seattle City Attorney Pete Holmes and WSLCB Member Chris Marr.

Seattle Attorney Pete Holmes was a keynote speaker at Canna Business & The Law

Seattle Attorney Pete Holmes was a keynote speaker at Canna Business & The Law.

MJBAProfessionalEducationSeminar

Pete Holmes and Chris Marr take questions

In June the MJBA moved into its HQ in Bothell, WA.  And to commemorate the occasion, we held an MJBA Women’s Alliance Held a picnic at the compound, with more than 70 cannabis ladies pitching in for “pot luck.”

In July, we launched the South Sound Tacoma MJBA meetup at Surge Tacoma. The first event was over-capacity and demonstrated that the need to support cannabis business was not just a Seattle phenomenon

Those getting into the marijuana industry today are getting a leg up on the growing wave of competition. The New York Times recently covered the industry that is now receiving financial backing from several networks of investors that are ready to plunge millions into the industry.

South Sound supports a robust MJBA community

For 4 days in August, MJBA was a VIP Sponsor of Cannacon V1.0 at the Tacoma Dome. Our MJNewsNetwork and Marijuana Channel One on YouTube covered the event extensively.  Canna personality Radical Russ Belville interviewed key MJBA business members for his 420 Radio Network.

LCB's Randy Simmons and David Rheins at CannaCon

LCB’s Randy Simmons and David Rheins at CannaCon

In August, MJBA also hosted a benefit for NORML at its Bothell HQ.  The event was sponsored by Blue Line Protection Group, O.pen Vape, Evergreen Herbal and Washington Bud Company.  NORML founder Keith Stroup, travel author Rick Steves, cannabis celebrity Cheryl Shuman, Washington NORML founder Kevin Oliver and High Times Editor Rick Cusick were all in attendance.  The event raised $1500 for NORML.

NORML's Keith Stroup, David Rheins and Kevin Oliver

NORML’s Keith Stroup, David Rheins and Kevin Oliver

In August, MJBA Women’s Alliance sponsored a benefit for the Pink Gene Foundation at Suite at the Hyatt in Bellevue.  $1000 was raised via a silent auction of donated wares from MJBA’s generous business members and sponsors.
PinkGene

Washington Bud Co's Shawn DeNae and attorney Stephanie Boehl

Washington Bud Co’s Shawn DeNae and attorney Stephanie Boehl

We held our first ever MJ Research listening summit in August, which informed our second MJBA Professional Education Seminar, “Technology & Your Cannabis Business”  held at the Motif Hotel in Seattle. Sponsored by CIPS, the event featured keynote presentation by Jamen Shively and ICCCO, and featured five all-star expert panels.

Ben Livingston Emceed MJBA's Technology & Your Cannabis Business Seminar

Ben Livingston Emceed MJBA’s Technology & Your Cannabis Business Seminar

MJBA at CannaCon 2014

MJBA’s David Rheins being interviewed at CannaCon 2014

In September, MJBA launched the Vancouver Meetup. The Mayor of Vancouver proclaimed the day “Cannabis Hemp Awareness & Marijuana Safe Usage Day” – Viridian Sciences was host, and Congressional candidate Bob Dingethal spoke to the group.  And we’d like to thank Danille Ulvila with Life Gro for hosting our most recent Tacoma Meetup at her impressive Life Gro facility.

Viridian Sciences hosted MJBA Vancouver's first meetup

Viridian Sciences hosted MJBA Vancouver’s first meetup

 

MJBA held its monthly Seattle meetups at Magial Butter Studios in SODO

MJBA held its monthly Seattle meetups at Magical Butter Studios in SODO

In September, MJBA launched MJBA Job Fair, a historic gathering of Washington Cannabis Industry’s employers and job seekers. Presented by Weedhire.com, and sponsored by Viridian Sciences, Eden Labs and Blue Line Protection Group, the event attracted more than 400 attendees, with 30 employer sponsors and more than 140 job openings.  We even hosted a “Marijuana Is Safer Than Unemployment” Fashion Show!

 

Job Fair Seattle was a huge success

Job Fair Seattle was a huge success

Eden Labs' CEO AC Braddock on the runway at the MJBA Jobs Fair in Seattle.

Eden Labs’ CEO AC Braddock on the runway at the MJBA Jobs Fair in Seattle.

In November, the Women’s Alliance hosted “The Power To Lead,” a day of inspiration, information and celebration, featuring Ladybud publisher Diane Fornbacher and financial guru Debbie Whitlock.

Ladybud Publisher Diane Fornbacher keynoted "The Power to Lead"

Ladybud Publisher Diane Fornbacher keynoted “The Power to Lead”

A couple of days later in November, MJBA Research published its first market research report, and held its third Professional Education Seminar:  “Dollars & Sense: Risk & Financial Planning for your Cannabis Business.” Sponsored by RMMC Consulting, the daylong event included a robust vendor area, and a daylong series of panels, including an hourlong Q&A with LCB Deputy Director Randy Simmons. 7 expert panel focused on actionable advice for the more than 200 I-502 licensees and applicants on their major areas of concern: financing and money management; insurance and risk; security, distribution and transportation; merchant service; business intelligence. MJ Freeway sponsored the 4:20 happy hour.

 

Dollars and Sense of Risk & Financial of Your Cannabis Business

Dollars and Sense of Risk & Financial of Your Cannabis Business

Just under 500 job seekers networked for opportunities to work in WA's legal marijuana industry.

500 job seekers came to MJBA Job Fair Seattle

In December 2014, the Company held its first annual “Cannabis Xmas Bazaar: Hot Pot Products for the High Holidays,” an historic showcasing of marijuana-themed products and innovations with participation by over 20 independent vendors and 150 members.   And, to top it all off, we were honored to be nominated as “Best Cannabis Association of 2014” in the Dope Industry Awards.  All in all, I’d say it was a fantastic first year in the life of a Green Rush startup.

Can’t wait to share what next year brings.  Hope you’ll stay tuned.  In the meantime, here’s wishing everyone a safe, happy, hempy holiday season.

The Cannabis Elders at the Dope Industry Awards

The Cannabis Elders at the Dope Industry Awards

 

Leafly sponsored Sativa Santa at MJBA Cannabis Xmas Bazaar

Leafly sponsored Sativa Santa at MJBA Cannabis Xmas Bazaar

Farmer Tom "Sativa Santa" and Seattle Hempfest's Vivian McPeak

Farmer Tom “Sativa Santa” and Seattle Hempfest’s Vivian McPeak

Michael Stusser and Higher Ground TV captured this year's Hot Pot Products

Michael Stusser and Higher Ground TV captured this year’s Hot Pot Products

MJBA’s Rheins Leads All-Star Panel On Canna-Marketing At CCC in PDX

In today’s hyper-competitive legal cannabis industry, excellent branding and marketing is essential.  It’s “Differentiate Or Die” says MJBA executive director David Rheins.  “It used to be that farmers could rely upon the quality of their crops and their reputation in the local community.  With commercialization, the quality and desirability of the product, must be communicated through meaninful branding, appealing packaging, and solid marketing.”

Rheins will be moderating a panel of leading cannabis industry marketeers at the 4th Annual Cannabis Collaborative Conference in Portland, January 24th.  The marketing panel will feature a number of top canna-brand experts including Stephen Gold, The Daily Leaf; Sean Lucas, NUG Digital Marketing; and Ryan Michael, KindTyme, as we discuss the top branding and marketing trends every canna-marketer must know.

  • Differentiate or Die!  Marketing Panel
  • 12:00 – 12:45pm, January 24
  • Room D204 (Seats 50)
  • Speakers: Dave Rheins, Sean Lucas, Ryan Michael and Stephen Gold

    Moderating the ancillary businesses panel at CCC

    David Rheins Moderating the marketing panel at CCC

Cannabis Now And Curved Papers Launch Rollout Of Three New Styles: RICE, RICE KING & HEMP KING.

NEW YORK: Curved Papers is always innovating. This year they have rounded out their product line with two sizes of another popular kind of paper, called rice, in the 1-1/4 and KSS sizes, and a KSS format organic hemp paper. The NORML Curved Papers are 100% organic hemp at the 1-1/4 size.

curved-riceCannabis Now will carry Curved Papers in an exclusive selection in their new dispensaries all over the country. They will celebrate together at the Cannabis Now flagship store in Beverly Hills, CA.
rice-king
CEOs Eugenio Garcia, of Cannabis Now, and Michael O’Malley, of Curved Papers, are old friends of MJBA Founder David Rheins from the Seattle daze, and have always looked for a way to work together. This multi-touchpoint program will include all aspects of Cannabis Now’s extensive media machine, social media, online content and physical presence in the brick & mortar empire of the MSO.

hemp-king

CURVED PAPERS GIVE YOU AN EDGE

While still finding ways to expand the reach of the easy to roll curved edge, the Great Vape Scare of 2019 sort of fell into Curved Papers’ lap this year. It has led many back to the traditional practice of smoking joints, which continues to dominate overwhelmingly anyway. Doctors and nurses agree, it’s not a bad way to take your meds. It’s not like smoking tobacco cigarettes, and, conversely, vaping is not like smoking a joint.

With a new emphasis on online sales, Curved Papers has introduced a Holiday Mixed Four Pack, in fact, two styles of it. They include each of the three new styles, RICE, RICE KING and HEMP KING, and either the original Curved Papers, our classics, which simply cannot be improved upon, or NORML Curved Papers, which are 100% organic hemp, and support the legalization leadership of NORML with a royalty through a licensing agreement. Help Make Marijuana Legal. Buy These Rolling Papers.

Rolling Paper Girls

‘I Can Still Do That Foundation’ & Tom Pacheco Premiere “Freida’s Secret Garden”

Shot in Humboldt County, the video uses local talent and filmmakers to promote cannabis legalization

NEW YORK: The I Can Still Do That Foundation, a New York City-based non-profit whose mission is to connect people so they can share information and empower each generation to teach the others, launched “Freida’s Secret Garden “  a pro-pot music video based on a song by legendary Woodstock singer-songwriter Tom Pacheco.

“The time to end irrational prohibition of cannabis is now,’  Dan Schneider, Executive Director of the Foundation, announced. “With 33 States now recognizing the benefits of medical cannabis and another 11 States legalizing recreational cannabis, a majority of Americans are in favor of legalization and the end of the irrational and Draconian laws which have stifled research on the potential benefits of cannabis. These laws have had a disparate impact on people of color and restoration of civil rights to those who have been adversely affected is also required to promote equity. The patchwork of irrational and inconsistent federal and state laws must end and the federal law must allow these now legal business to access the federal banking system to that black market producers of questionable products can be replaced by healthy and tested, legal cannabis and CBD products.”

“We want to thank advisor Lelehnia DuBois and her friends in the Humboldt County for helping us make the new music video,” Schneider said. “You can see the new video here in a sneak peek. Please share it with friends. We are trying to help Tom get the recognition he deserves as a legendary singer/songwriter who has written songs for Bob Dylan, The Band, Jefferson Starship, and others. He has a music publishing catalogue of more than 500 songs; “Freida’s” is just one of many great ones.

Still Do That advisor, Curved Papers Founder Michael O’Malley, said, “This song and video bring together the West Coast and East Coast hippie vibes – from Humboldt County to Woodstock – that have given rise to the contemporary cannabis legalization movement. Call it Cannafest Destiny. The fun, the healing compassion and sensible restoration of marijuana’s rightful place in society are all captured humorously in Tom’s lyric and rocking rhythm.

David Rheins, founder of the Marijuana Business Association and Still Do That Advisor agreed: “Marijuana has gone mainstream, and the mainstream media is now getting hip to the power of the plant and the amazing possibilities that legalization brings.  Through the work of artists and activists like  Tom Pacheco,  we are raising cannabis consciousness, and dispelling the dangerous myths and harmful policies of prohibition.”

Still Do That Advisor Melissa Gibson, founder of Hemp and Humanity said, “This folksy and campy musical send-up to the authentic cannabis lifestyle pays homage to the plant, place and people who have championed it for generations. As marijuana use reaches a tipping point in mainstream acceptance, and the cannabis industry has attracted big business, Tom Pacheco take us back to the root(s) of this plant and its essential spirit of connecting humans with one another. What Frieda and her happy, hippy grandson Paul know, is that cannabis has the power to heal, clothe, feed, house, fuel and sustain human’s ability to live on this earth. And that’s worth singing about.”

Still Do That Advisor Lelehnia DuBois, cannabis community advocate and Sensi Magazine publisher, who co-produced the video and played the title role of Freida added, “I come from a culture of Frieda’s. It felt like she was my own mother. It was an honor to play the role”

According to Schneider, an entertainment lawyer by trade, the Foundation plans to produce a weekly TV news series called, “High Hopes”,  to educate people on the history, legal issues, health issues, science and finance surrounding the booming legal cannabis industry.  “We may even use Tom Pacheco’s song as a theme song for our TV series,” Schneider said. “We are currently looking for partners and sponsors for the series and are particularly interested in pro-cannabis celebrities to help demystify the stigma surrounding cannabis.”

Marketing Thru Marijuana: Differentiate or Die

This is the year that hippie cannabis dies. Woodstock is 50, and has just licensed its name to mega-retailer MedMen.  Hemp is newly de-scheduled and igniting the imaginations of farmers and investors excited about the global opportunity.  Pot Culture has become Pop Culture as legalization has spread coast-to-coast and pushed marijuana into the mainstream.

For grassroots marketers who have been playing in our fragmented American marketplace — where no two states share identical regulations or standards — things have gotten tough in the last year as legal competition from Big Pharma, Big Alcohol, Big Tobacco, Big Consumer Package Goods and Big Agriculture have transformed the playing field.

“As our nascent industry rockets from grassroots to global, it’s Differentiate or Die time for independent companies hoping to stay relevant in an increasingly noisy landscape.” MJBA Founder and veteran marketer David Rheins told MJNews Network.

“You must be able to stand out from the cacophony.  My advice for the licensed cannabis business and ancillary provider alike, is to focus on defining your brand differentiation.  Find a niche, fill a niche.  Your competition moving forward is Big Industry, which has the money, the technology and the wherewithal to take a product from field or factory to shelf better than the little guy ever will.”

His advice: Build your brand authority.  “Big Industry doesn’t understand emerging markets — who the consumer are, their buying preferences and psychographics,” Rheins said.  “As a small business, you are part of the community. You are making a market — defining the industry and your space in it.  No one understands its needs and attitudes of the new market better than the grassroots marketer.  Build your brand around your values, and the values of your customers and your community.   Establish brand loyalty and authority — with your vendors, and your customers, wether you are b2b or b2c — by lending value.”

Differentiate Or Die

Rheins suggests that the New Year is a good time for all marketers to do a brand review.  As an exercise, he encourages his clients to ask their investors, employees, vendors and customers to answer a couple of questions:

1) Describe our brand value  — what do we stand for — in one sentence.

2) What products/services do we offer.

3) What is our unique selling proposition (USP) — what do we do better than other brands?

“You’d be surprised how much intelligence you’ll gain just by analyzing these questions,” Rheins said.  “It only goes to reinforce that today marketing is not simply an exercise of spending money on paid advertising.  Advertising — particularly targeted placements — can be effective, but savvy marketers today depend on an integrated strategy that includes owned media (your company websites and newsletters) and earned media — social media engagement on public platforms with business communities and groups on Facebook, Twitter, Instagram, Reddit.

In this dynamic environment, Rheins advises businesses to stay engaged and stay fresh.

Take An Annual Brand Checkup

1) Do A Brand Review: How well do your customers understand your Brand Values and USP? How well do you understand your customer segments?

2) Website Audit: How fresh is your content? Are you SEO optimized? Are you using your website to gather customer feedback?

3) Social Media Audit: How visible is your brand on key social media platforms?  How often do you post content?  How quickly do you respond to queries or brand mentions? Who in your company is responsible for social media?

4) Community Check Up: How engaged is your brand in your community — not just your cannabis community but your local community?  Do you sponsor local events? Do you give to local charities? How well liked is your brand on Main Street?

 

 

MJNews Exclusive Interview With Saul Kaye, CEO/Founder iCAN: Israel Cannabis

Since the 1960s, Israel has led the world in medical cannabis research. Now, as international markets emerge for legal medical cannabis, the country is poised to become a major global player.  Recently, the Israeli Parliament caused a great deal of industry excitement when it passed a bill that would pave the way for Israel to become an exporter of both cannabis flower and, perhaps more significantly, the intellectual property and data from its seminal research and clinical trials.

For the past five years, iCAN: Israel Cannabis and its CannaTech conferences have been instrumental in shaping the Israel medical cannabis landscape.  In this exclusive interview held on New Year’s Eve, MJNews’ editor David Rheins talked to iCAN CEO and Founder Saul Kaye.  The interview is now live on MJChannelOne.

Saul Kaye:         My name is Saul Kaye. I’m the CEO and founder of iCAN: Israel Cannabis. We’re ecosystem builders. We started in the cannabis space in Israel about five years ago and help to build a new way of talking around cannabis and how to approach this both as a medicine and an industry and had some success around the world. And today we primarily go to governments, go to the industry and find synergies between various companies, incubate great ideas in the cannabis space and put on awesome events that educate people about cannabis and the wonders of cannabis medicine and how it’s going to change the world.

MJNews:          So, we’re at some auspicious news here at the end of 2018. The Israeli Parliament has just passed an export law — can you share with us what that means? What are the prospects for the prime minister signing that into law and what does that portend for us in the coming months?

Saul Kaye:         Sure. So it’s another step in a long process that’s been going on for a long time. It’s not the end of the process. It’s not that tomorrow we can export, but the Knesset, our ruling parliament at the time, before it was just the dissolved, said we unanimously want export to happen. Now it’s the policy’s job to go and make that happen. So, the last thing that has to happen is Bibi has to sign it into law. But now there is no, you know… the focus is maybe on getting reelected. I don’t know if that’s going to happen before the coming elections or whether we’re going to have to wait. I think cannabis is going to be a major issue in the upcoming election. So right now, what does it mean? It means there is a desire from our cabinet, from our legislature to make sure that export does happen.

iCAN | Israel Cannabis

Saul Kaye:         I don’t think we’re going to go backwards and have to revisit that. There’s a clear desire that Israel continue to be a leader in this industry. And I think that it’s now just a matter of playing out the end of the chess game: having everything signed and sealed, and then export will happen.  At the same time, you have to remember that the companies here in Israel and not scaled up yet for export.  You know, we’ve all been waiting to see how it’s going to play out. Lots of promises from the side of the government and it took her time, but I think that’s going to give these companies now an opportunity to begin scaling for the massive demand that exists overseas.

MJNews:          It’s fascinating. the Israeli approach to medical cannabis has been an almost 180 degree opposite approach to what we see here in the United States. Obviously, Israel was a pioneer back starting as early as the 1960s identifying THC and working to unlock the medical implications of cannabis, and you’ve approached it from a systemic point of view — meaning that we have Israeli hospitals and physicians and the medical establishment, if you will, working together on medical cannabis. Compare and contrast that with the US, which has had a patchwork of grassroots, assorted voter initiatives that have empowered cannabis entrepreneurs, but not really provided the infrastructure for medical research. How are those two systems coming together? And where does export fit in, and what exactly are we talking about in terms of export moving forward?

Saul Kaye:         So, you know, the first part to what’s unique and what’s worked about Israel is that we didn’t have the noise of the recreational market. We had a research focus to help the really sick, and it wasn’t easy to get. It’s really complicated, and you’ve got to be really ill to get it. So there are lots of holes we can poke in these Israeli system. It’s not perfect, but what it did do is say ‘Patient First,’ let’s give them some medicine and see what happens. And over time, helped to develop an infrastructure that allows for that and now it’s really moving into the new phase: what they promise of doctors being educated, pharmacists being educated, and it becoming just like another medication in the arsenal of the toolkit of doctors to use.  So that, you know, from a perspective of understanding both the regulator side, yes, it takes time to regulate this — to allow the stigma to dissolve.

Screenshot 2018-12-31 11.59.16

Saul Kaye:         Also, over time, we’ve seen more clinical trials that have proven that it works, and that it helps and that it is sometimes better than pharmaceuticals. And all of this has led to sort of a tipping point at this time where we can now all say… Well, you know, how come it didn’t happen 10 years ago?  Because we didn’t have the amount of information we have. So stigma was much stronger. So all of those things happened. And that’s what happened in Israel. And it’s one of the places where you’ve got two degrees of separation, sometimes even one degree of separation. So, if Professor Mechoulam, who is in Jerusalem, needs something that’s being done by Dr. Dedi Meir at the Technion — that’s a two-hour drive. Everyone knows everyone. We’re all family. Also, from a patient perspective, most people in Israel know a patient that has received medical cannabis for cancer.

It’s probably grandmother, or one of grandmother’s friends, and they’ve seen it helping and it’s been around a lot. So that singular focus of helping patients — even though there’s a bureaucratic nightmare in order to get it — has given Israel a leading edge. Now why do countries need Israeli cannabis? You know, from a US perspective, California doesn’t need Israeli cannabis. But as countries start to look at regulating cannabis, they are going to institute their own regulations. This will take six months to 12 months to write, then they are going put out a tender. Then everyone’s going to start. You’re talking two and a half years of no cannabis in the country as they begin to regulate. So what do you do with those patients that currently need cannabis  — that has been proven in Israel to work for epilepsy or for Crones, for Parkinson’s, you know, the things that we’re investigating here in Israel — and you get to a point where net exporters have a market for at least very short term, say one year to five years of entering new markets.

Saul Kaye:         And we also have knowledge both in growing cannabis, turning it into medicine, dosing and doing clinical trials.
That knowledge is something that we’re transferring overseas. So, we are both a net exporter of knowledge and a net exporter of cannabis product.

Screenshot 2018-12-31 11.58.28MJNews:          So, put some numbers to that. How big is the Israeli medical cannabis — physical cultivation, the physical production? How much cannabis is being produced in Israel?

Saul Kaye:         Uh, it’s a really good question. So, the, the old numbers before this whole new regulation came in, were eight [licensed] growers with a capacity to supply the market — at that stage, Israel had about 30,000 patients — around 10 to 12 tons. The new capacity of Israel is in the hundreds of thousands of tons. So that’s going somewhere. It’s not going to be diverted to the black market in Israel. It’s not going to be a play in Israel, it is all slated for Germany, the Czech Republic, Europe, Australia, et cetera. In in terms of money, what they’re saying that it’s $2Billion worth of industry in the next two years. In terms of numbers [moving forward], I’ve seen numbers up to $33Billion in the next five years. So, it’s a large thing.

MJNews:          The 33 Billion — that’s inclusive of intellectual property? Is IP really the big opportunity? I’ve been really excited about watching the progress in Israel of legitimate medical research. As you know, because of federal prohibition, while we have robust legal cannabis markets here in the States, and getting bigger and adding every day, that is changing, we really are behind the gun and so I’m looking at sort of the immediate opportunity, for the US? And quite honestly, our brothers to the north, the Canadians, are very aggressive as you know, because they have the public markets.  And they are investing in production, investing in IP. So, to what extent can the Israelis helped to jumpstart legitimate research here in North America? And then tell me why you’re looking at markets like Panama, for example, and, investing time and energy there.

Saul Kaye:         So, the first question, what does Israel offer to the big Canadian and US companies? Accelerated access to patients, to data. I can begin clinical trial very quickly in Israel. We very [closely monitor] our patients using cannabis, so we can see what that does for another condition. We’re an active, innovative startup nation. So, what we’re seeing in our startup world is quite differentiated for what I’m seeing at MJBizCon as an example. We’re really IP-driven tech companies — the same as we did in cyber security and the same as we did in the car automotive space. It needs so many other industries. We’re disrupting here as well. So, you know, my deal flow I think is better than what we’re seeing in the US. We’re not focusing here on ‘I’m a vertically integrated cannabis company and my specialty is I’m going to be a lifestyle brand.’  Well, that’s everyone. Oh, and ‘I’m going to be GMP.’ Can you imagine people going to a pharmaceutical conference, standing onstage and go, ‘I’m super proud. I’ve got GMP.’ We’re way beyond that conversation here in Israel. So yes, of course you need those standards, but yeah, we’re really going to disrupt this.

Screenshot 2018-12-31 11.58.13MJNews:          I want to thank you for all your time. I have a couple of last questions. Talk a little bit about standards, because it is something that plagues the industry. First of all, we’ve been spending most of our time this morning talking about medical cannabis, but, the implications for industrial hemp, for example, not to mention consumer package goods and all the implications of the recreational adult-use market — it’s a very wide horizontal opportunity with lots of segmentation in terms of the channels and the audiences. Tell me a little bit about those standards. You’re talking about GMP, which is something that has opened up international cannabis when it comes to medical, when it comes to defining those standards, how do activities and research in Israel sync up what’s going on, with folks at GW pharmaceuticals or what the FDA is looking at now with some relaxed and revised policies. Uh, how do we get agree upon common standards so we can all invest properly?

Saul Kaye:         So, you know, the government system here is what they call the five books — setting up nursery, cultivation, production, distribution and patient under separate licensing. Similar to vertical integration in Canada. Here in Israel, the focus has been that this is just like every other medicine. It is dispensed in pharmacies by a pharmacist. It is considered a narcotic. So we have no aspect of a recreational market. This is a serious medicine. You need to get serious doctors behind your treatment and your pharmacist to be involved in your treatment. So that’s how it’s playing out in Israel. So, it’s less of a recreational focus, but definitely more on the medical. So, the standards also, if you’ve got an immune compromised patient that’s taking an inhaled product of cannabis, we better be sure that it has no mold and pesticides.

Saul Kaye:         So, the standards for Pharma are just more rigid than the standards for cannabis as a food will have. It’s one standard: cannabis as a pharmaceutical. And that includes a standard of how you grow it, how you process it, how you clean it. And obviously packaging, distribution, security, all those things around cannabis. Those all need their regulations. What I can do as a company is to come in before government has regulated and help them get good regulation.  There’s a process that makes sense from an industry perspective and a security perspective. Remember the two most important things we want to do is make sure that there’s no diversion — there were not supporting the black market — and make sure that the quality is good. And if we do that, then the black market disappears and we get good cannabis regulations. And so we as a company come in to try and help governments do that.

saul kaye and david rheinsMJNews:          Fantastic. Here we are at New Year’s Eve. What are your predictions for 2019? What will medical cannabis in Israel look like 12 months from today?

Saul Kaye:         That’s a good question. I hope that we’ve doubled our patient numbers. That we have published all of the claims that have been made. because it’s very easy to say I’m doing a cannabis study. And there are two hundreds of those going on right now. I want to see that data published because that is what will push sort of ‘Cannabis 3.0’ in new countries. They can now say, ‘the data is there, the clinical trial has been done. And then we, Israel, will help to move cannabis forward everywhere.

MJNews:          And iCan, where will you be in 12 months from today? How many markets? You’ve got three aspects to your business. You’ve got the service aspect, the R & D; you’ve got the incubator; and you’ve got your CannaTech events. Where do you see the emphasis, for your company in the coming year?

Saul Kaye:         We, as a thesis, go after the emerging markets, so that’s why we’re going to [focus]. Panama, Latin America is forgotten with cannabis right now. There are 550 million people down there who will consume cannabis in the next year through legal channels. So Latin America is very important. Africa, CannaTech is going to go to Africa towards the end of 2019. Also, Africa is heating up and going to be a very interesting market. Both of those markets are driven by low-cost production of cannabis, which could decimate what’s going on around the world. That’s going to become very interesting to see how those new markets affect the more established markets. And we’ll be in Europe as well. So, you know, we’re staying out of the US right now — there’s a little too much noise in the conference space — and really focusing on the new emerging markets. So, we’ll be looking in Italy, in Europe, and somewhere in Africa and we’re about to be in Panama in February, which is going to be an awesome show. You should come down.

MJNews:          Fantastic. How do folks get ahold of you? And what are you looking for? You’re looking for investors. You’re looking for intellectual property. You’re looking for governments? Where’s your business development focus?

Saul Kaye:         Across all three. So, if you’d like to attend the CannaTech, or sponsor at CannaTech, let us know [website] that the, you know, usually goes through Joshua. If you have intellectual property or a company, or an idea that you’re looking to incubate in the cannabis space and it has an application for global effect — don’t come to me if you want to be a grower in Oregon, that’s not the type of deals we’re looking for — and obviously investors who want a pipeline of early stage companies that are going to disrupt this industry for the next very long time. Come to me. I’ve got an awesome portfolio of companies looking for support.

MJNews:          Fantastic. CEO/Founder Saul Kaye. thank you so much sir. I really appreciate your time.

Saul Kaye:         Thank you. Happy New Year.

 

New MJBA PSA Reminds Us: Everything Plastic Can Be Made From Hemp

NEVADA: The Marijuana Business Association (MJBA), a leading national cannabis business organization and publishers of this website, today launched a national PSA campaign to raise awareness among industry professionals of the many uses of hemp, particularly as an alternative to eco-unfriendly plastics.

Everything Plastic Grinder“Everything plastic can be made from hemp” reads the headline of the series — and images showcase some of the thousands of petrochemical-based products that can easily be made from hemp.  Striking photography features cannabis packaging items like the plastic doob tube and the mylar bag — ubiquitous scourges plaguing the newly-legal industry.

Everything Plastic Sunglasses

“Now that the Farm Bill has been signed, and hemp has been descheduled, it is time for the legal cannabis to take the lead in educating the public about the many benefits and innovations available with hemp,” said MJBA Founder/Executive director David Rheins. “As a first step, I’d like to see us reduce the use of mylar bags and plastic jars and doob tubes immediately — and begin incorporating hemp into our industry’s packaging.”

Everything Plastic 2

 

The PSA campaign, created in-house, will run on the MJNews Network and its vast social media network, as well as national distribution across Higher Ground, 420MEDIA and Marijuana Channel One.  Other networks are expected to pick up the campaign.

 

Everything Plastic jarNew creative iterations are expected to run throughout 2019, and plans call for television executions.  For more information about participating in MJBA’s PSA efforts, email us at: info@mjba.net

European-American Cannabis Business Conference Is Oct 5&6 In LA

CALIFORNIA: EuroAm CBC is a set of trade-oriented conferences focusing on closer cooperation and trade Exchange between Europe and America. Based upon the success of Cannafest Prague, the largest cannabis trade show in the world, organizers have decided to export the first American edition of the show, taking place in Los Angeles, October 5–6, 2018.

The pilot edition of this international conference was held straight before Cannafest Prague 2017, where it was very well received and the organizers now decided to bring it also to the American shores. “The main purpose of the conference is to connect the traditional European cannabis markets, where some companies have been active for more than thirty years, with emerging markets in America,” says Lukáš Běhal, the founder of the conference and CEO of Cannafest Prague.

EuroAm CBC L.A. 2018 is thematically divided into four sections focusing on Europe, the United States, Canada and South America, and will welcome world-known professionals, who will share their valuable insights into the world of cannabis business. You can look forward to presentations of David Rheins (MJBA), Vin Maru (Invest in MJ), Lukáš Běhal (Cannafest) and many others.

The conference will take place in the beautiful space of the Hollywood Roosevelt Hotel, situated in the heart of Hollywood, along the legendary Walk of Fame. Tickets for are now available in pre-sale.

EuroAm CBC LA is Oct 5&6

EuroAm CBC LA is Oct 5&6


EuroAm CBC L.A. 2018

October 5–6, 2018

Tickets: $200 – $399

Location: The Hollywood Roosevelt Hotel,

7000 Hollywood Boulevard, L.A, CA 90028